Stories similar to Pulmonary Arterial Hypertension - Pipeline Review Market:

Pruritus - Pipeline Review Market 5 days 12 hours ago

'Pruritus - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides A snapshot of the global therapeutic scenario for Pruritus. A review of the Pruritus products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.

Infections Caused By Picornaviridae - Pipeline Review Market 1 day 12 hours ago

The scope of the reports is as follows :

Scope

- A snapshot of the global therapeutic scenario for Infections Caused By Picornaviridae.
- A review of the Infections Caused By Picornaviridae products under development by companies and universities/research institutes based on information derived from company and industry-specific sources. and many more......

Chronic Cough - Pipeline Review Market 3 days 10 hours ago

The Scope of the report is as follows :

- A snapshot of the global therapeutic scenario for Chronic Cough.
- A review of the Chronic Cough products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.

Understanding Hypertenstion - Facts you Should Know 2 years 28 weeks ago

Hypertension is no joke. With the epidemic of obesity in the US, we are also seeing a rise in hypertension. One in three or over 75 million American children and adults suffer from high blood pressure. It is the number cause of heart attack and stroke. More than 65% of people with hypertension do not know it. High blood pressure slowly and this is why it is often overlooked.

Malignant Mesothelioma Pipeline Review 2 years 44 weeks ago

Malignant Mesothelioma - Pipeline Review, Q1 2011', provides an overview of the Malignant Mesothelioma therapeutic pipeline. This report provides information on the therapeutic development for Malignant Mesothelioma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Malignant Mesothelioma.